share_log

Lyell Immunopharma | 3: Initial statement of beneficial ownership of securities-Director Ramachandra Sumant

SEC ·  Nov 1 20:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more